Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen as a Perioperative Analgesic Adjuvant
NCT03720717Phase 4Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of baclofen in postoperative pain (4 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Postoperative Opioid Requirements at 24 hours. Started Oct 2020; status: terminated.
02
Drugs
baclofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03720717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720717.